WBH ADVISORY INC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
WBH ADVISORY INC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2021$212,000
-10.9%
1,9110.0%0.03%
-17.1%
Q4 2020$238,000
-3.6%
1,911
-11.2%
0.04%
-19.6%
Q4 2019$247,000
-11.5%
2,152
-2.7%
0.05%
-19.0%
Q3 2019$279,000
+3.3%
2,212
-1.7%
0.06%0.0%
Q2 2019$270,000
+14.4%
2,250
-4.7%
0.06%
+10.5%
Q4 2018$236,000
-12.6%
2,3600.0%0.06%
-12.3%
Q3 2018$270,000
+20.5%
2,360
-5.6%
0.06%
+12.1%
Q2 2018$224,0002,5000.06%
Other shareholders
HAEMONETICS CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Iron Triangle Partners LP 330,000$36,633,0004.66%
BEACONLIGHT CAPITAL, LLC 156,395$17,361,0002.80%
Bridge City Capital, LLC 48,011$5,330,0001.77%
Summit Creek Advisors LLC 121,362$13,472,0001.61%
Sivik Global Healthcare LLC 25,000$2,775,0001.01%
ANCHOR CAPITAL ADVISORS LLC 412,218$45,760,0000.97%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 69,655$7,732,0000.90%
Orbimed Advisors 852,000$94,581,0000.88%
LONDON CO OF VIRGINIA 1,057,738$117,420,0000.67%
WEXFORD CAPITAL LP 40,138$4,456,0000.66%
View complete list of HAEMONETICS CORP shareholders